First, to further determine the clinical relevance of WDR5 in prostate cancer, we analyzed the expression of WDR5 in 262 archived human paraffin-embedded prostate cancer tissues from two cohorts (cohort 1 and cohort 2) using immunochemistry. The gene discussed is WDR5; the disease is prostate cancer.